ABCA7 p.G215S as potential protective factor for Alzheimer's disease

Area of Science:

• Genetics
• Neuroscience
• Complex Disease Research

Background:

• Genome-wide association studies (GWASs) have identified over 20 Alzheimer's disease (AD) susceptibility loci.
• The genetic architecture of these loci, particularly rare and low-frequency coding variants, remains underexplored.
• Understanding diverse genetic contributions is crucial for dissecting complex disease pathogenesis.

Purpose of the Study:

• To analyze the effect of rare and low-frequency protein-coding variants in nine top AD GWAS loci.
• To investigate the role of these variants in sporadic Alzheimer's disease risk.
• To identify novel genetic factors contributing to AD pathogenesis.

Main Methods:

• Exome and genome sequencing data were analyzed in a cohort of 332 sporadic AD cases and 676 controls.
• Focus was placed on coding variants within nine AD GWAS loci with the strongest effect sizes (excluding APOE).
• Statistical analysis was performed to assess the independent and joint effects of these variants.

Main Results:

• A low-frequency coding variant (p.G215S, rs72973581) in the ABCA7 locus was identified.
• This variant confers a statistically significant protective effect against Alzheimer's disease (OR=0.57, P=0.024).
• The protective effect was not driven by an enrichment of loss-of-function variants in ABCA7.

Conclusions:

• The study confirms the role of ABCA7 in Alzheimer's disease pathogenesis.
• A specific coding variant in ABCA7 provides protection against AD, independent of loss-of-function variants.
• Findings provide novel insights for future functional studies on AD genetic risk factors.